Health Care/Hospital

World Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target

SHANGHAI, March 21, 2026 /PRNewswire/ -- On the occasion of World Water Day, WuXi Biologics reaffirms its commitment to sustainability through responsible operations and efficient, circular water‑use practices that reduce environmental impact. W...

2026-03-22 09:30 4057

Dizal Announces Positive Topline Phase 3 Results from WU-KONG28 Study: Evaluating Oral, Once-Daily ZEGFROVY® (Sunvozertinib) vs. Platinum-Containing Chemo Doublet in First-Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Mutation (exon20ins)

* Treatment with ZEGFROVY® resulted in statistically significant and clinically meaningful improvement in progression free survival (PFS) over platinum-containing chemo doublet * WU-KONG 28 is the first and only phase 3 study to demonstrate meaningful benefits with an oral, once daily, chemo-...

2026-03-21 19:26 7209

SiiPet Highlights Spring Health Priorities for Cats as Seasonal Initiative Expands Access to AI‑Driven Monitoring

LOS ANGELES, March 20, 2026 /PRNewswire/ -- SiiPet , a growing pet tech startup, announced itsSpring Sale initiative, running from March 15 to March 31, marking a renewed effort to make advanced feline health monitoring more widely accessible during a season when many ca...

2026-03-20 20:00 5135

Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development

WILMINGTON, Del., March 20, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced that it has raised$787 million in financing rounds. The investment included participation by a group of leading global investors, including Dimen...

2026-03-20 19:30 5127

GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer

SEOUL, South Korea, March 19, 2026 /PRNewswire/ -- GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) in a phase1b clinical trial. ...

2026-03-20 09:29 3340

Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials

BELLEVUE, Wash., March 19, 2026 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a healthcare-focused holding company advancing innovative medical technologies, today announced that its subsidiary, Woori IO Co., Ltd. ("Woori IO"), has entered into a mutual non-disclosure agreement ("NDA") with ...

2026-03-19 21:44 5510

Graphy Hosts 'SMA Legends Symposium 2026'… Spotlight on Digital Orthodontics

Global orthodontic experts gather to present SMA-based clinical strategies and accelerate the adoption of next-generation digital orthodontic solutions. * Global Symposium: Expanding Clinical Exchange Across 15 Countries The symposium brought together around 300 participants from 15 countries, ...

2026-03-19 21:00 4233

Bambusa Therapeutics Appoints Todd James Chief Financial Officer

- Mr. James brings more than 20 years of biopharmaceutical leadership experience, with deep expertise in capital markets, investor relations, and corporate strategy, serving in senior executive roles at Acceleron Pharma prior to its$11.5 billion acquisition by Merck and at Viridian Therapeutics -...

2026-03-19 20:30 6721

Ractigen Therapeutics Announces China NMPA IND Approval for Phase II Clinical Trial of saRNA Therapy RAG-01 in Non-Muscle Invasive Bladder Cancer

NANTONG, China, March 19, 2026 /PRNewswire/ -- Ractigen Therapeutics, a pioneering clinical-stage biotechnology company developing innovative small activating RNA (saRNA) therapeutics, today announced thatChina's National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has...

2026-03-19 20:10 5261

Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 19, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced the appointmen...

2026-03-19 14:42 5298

Beyond Static Seating: LiberNovo's Spring Promotion for a More Human-Centered Workspace

HONG KONG, March 18, 2026 /PRNewswire/ -- The seasonal transition into spring has traditionally focused on the physical environment—the decluttering of spaces and the refreshing of aesthetics. However, as the boundaries between professional productivity and domestic life remain permanently blurre...

2026-03-19 01:00 5328

SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support

* Largest-ever grant from RIGHT Foundation to accelerate Phase 1b clinical trial of RSV preventive antibody * Technology licensed from Gates MRI; early studies confirm suppression of RSV infection * Targeting global markets while addressing unmet needs in developing countries INCHEON, South...

2026-03-18 20:00 5421

DCwire® Micro Guidewire Receives FDA 510(k) Clearance, Marking a Key Milestone in Peijia Medical's Global Expansion

SUZHOU, China, March 18, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced that its DCwire® Micro Guidewire has received 510(k) clearance from the U.S. Food and D...

2026-03-18 20:00 4103

Taiwan's CMUH Achieves World's Only Perfect HIMSS Digital Health Score

TAICHUNG, March 18, 2026 /PRNewswire/ -- China Medical University Hospital (CMUH) has become the only healthcare institution worldwide to achieve a perfect score in the 2025 HIMSS Digital Health Indicator (DHI) assessment, highlighting the accelerating role of digital transformation and artificia...

2026-03-18 20:00 4377

LEIFRAS Co., Ltd. Obtains Membership with the Nippon Sport Policy Commission

To Support National Sports Policy and Accelerate Community-Based Transition of School Club Activities TOKYO, March 18, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and community engagement, is pl...

2026-03-18 15:00 3879

Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy

TAIPEI and SAN DIEGO, March 17, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that its first-in-class investigational drug Pidnarule...

2026-03-18 07:00 6819

Health In Tech and Amazon Web Service Advanced Tier Service Partner Ciklum Announce Strategic Collaboration to Accelerate Development of AI-Driven InsurTech Platform

STUART, Fla., March 17, 2026 /PRNewswire/ -- Health In Tech, Inc. (the "Company" or "Health In Tech") (Nasdaq: HIT), an AI-enabled InsurTech platform company, today announced a strategic collaboration with Ciklum, a global AI-powered experience engineering and softwar...

2026-03-18 04:01 7795

Co-PSMA data presented at EAU Annual Congress 2026 with manuscript accepted for publication in the European Urology journal

HIGHLIGHTS * Oral presentation on key results from the Co-PSMA (NCT06907641 )[1] Investigator-Initiated Trial (IIT) was delivered by ProfLouise Emmett (St Vincent's Hospital Sydney) at the European Association of Urology (EAU) Congress 2026 on the ...

2026-03-17 21:01 6228

Global Aesthetic Trends Evolve Toward 'Anti-Sagging': The Expansion of the Structural Skin Laxity Improvement and Liquid Type PCL Collagen Stimulator Market

SEOUL, South Korea, March 17, 2026 /PRNewswire/ -- The global medical aesthetics market is rapidly shifting toward an "Anti-Sagging" paradigm, focusing on improving the fundamental causes of skin laxity. While traditional aesthetic approaches primarily addressed external signs of aging—such as w...

2026-03-17 12:33 4695

Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA

SHANGHAI, March 16, 2026 /PRNewswire/ -- Monday, March 16th at 1:30 PM PT, Viva Biotech (01873.HK)optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, a receptor critical in muscle wasting and lean mass imbalance, aiming to accelerate the discovery of n...

2026-03-17 09:00 3228
1 ... 12131415161718 ... 317